Copyright
©The Author(s) 2016.
World J Hepatol. Aug 18, 2016; 8(23): 985-993
Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.985
Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.985
Figure 1 The levels of P-glycoprotein, mdr1 and nuclear factor-κB expression in different cell lines.
A and C: The levels of P-gp and NF-κB expression in HepG2 or HepG2/ADM cells were determined by Western blot. The number indicates the ratio of HepG2/ADM cells to HepG2 cells (n = 3, mean ± SD); B and D: The gray intensity images of Figure 1A and Figure 1C, respectively; E: The levels of mdr1 and NF-κB mRNA expression were determined by qRT-PCR. bP < 0.01 (n = 3, mean ± SD), compared with hepG2 or LO2 cell line. P-gp: P-glycoprotein; NF-κB: Nuclear factor-κB; ADM: Adriamycin.
- Citation: Wu W, Yang JL, Wang YL, Wang H, Yao M, Wang L, Gu JJ, Cai Y, Shi Y, Yao DF. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription. World J Hepatol 2016; 8(23): 985-993
- URL: https://www.wjgnet.com/1948-5182/full/v8/i23/985.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i23.985